iOncologi, Inc. (iOi) is an innovative biotechnology company dedicated to pioneering novel immunotherapies for the treatment of refractory cancers and infectious diseases. With a strong emphasis on addressing the unmet medical needs of cancer patients who do not respond to existing treatments, iOncologi is at the forefront of transforming cancer therapy through advanced scientific research and development.
Company Values
iOncologi stands out due to its exclusive rights to cutting-edge stem cell therapies and mRNA vaccine technologies, coupled with its comprehensive approach that integrates genomics and artificial intelligence in the fight against refractory cancers.